Investigation Says Drugmakers Manipulate Orphan Drug System

Drugmakers are manipulating the Orphan Drug Act -- which offers lucrative financial incentives in order to motivate pharmaceutical companies to develop rare disease drugs -- to maximize profits and to protect niche markets, says a Kaiser Health News investigation.

Source: PharmaManufacturing.com - January 17, 2017 Category: Pharmaceuticals Source Type: news